தினமலர் டிவி
Podcast
iPaper
சினிமா
கோயில்கள்
புத்தகங்கள்
Subscription
திருக்குறள்
கடல் தாமரை
/
செய்திகள்
/
Kalvimalar
/
News
/
FDA approves video game for treating ADHD in kids
/
FDA approves video game for treating ADHD in kids
UPDATED : ஜன 01, 1970 05:30 AM
ADDED : ஜூன் 16, 2020 12:00 AM
நிறம் மற்றும் எழுத்துரு அளவு மாற்ற
Boston: The US Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children.
The FDA said on Monday the game built by Boston-based Akili Interactive Labs can improve attention function.
The game, called EndeavorRx, requires a prescription and is designed for children ages 8 to 12 with certain symptoms of ADHD.
It's the first time the FDA has cleared a digital therapy for improving ADHD symptoms, and the first time the agency has ever authorised marketing of a game-based therapy for any condition.
The FDA says it looked at data from multiple studies in more than 600 children.
A video of the game shows a character travelling a racecourse-like path in a hover board. Sensory and motor tasks are designed to help the player improve cognitive functioning.
“We're proud to make history today with FDA's decision,†Akili CEO Eddie Martucci said in a statement. “We're using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment."
The FDA said on Monday the game built by Boston-based Akili Interactive Labs can improve attention function.
The game, called EndeavorRx, requires a prescription and is designed for children ages 8 to 12 with certain symptoms of ADHD.
It's the first time the FDA has cleared a digital therapy for improving ADHD symptoms, and the first time the agency has ever authorised marketing of a game-based therapy for any condition.
The FDA says it looked at data from multiple studies in more than 600 children.
A video of the game shows a character travelling a racecourse-like path in a hover board. Sensory and motor tasks are designed to help the player improve cognitive functioning.
“We're proud to make history today with FDA's decision,†Akili CEO Eddie Martucci said in a statement. “We're using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment."
Advertisement